Flexion Therapeutics (FLXN) Announces Proposed Convertible Senior Notes Offering
Tweet Send to a Friend
Flexion Therapeutics, Inc. (Nasdaq: FLXN) today announced its intention to offer, subject to market and other conditions, $125 million principal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
